scPharmaceuticals Inc SCPH
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Shares Outstanding
- 53.68M
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 5.89
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs. The company's main product is Furoscix to treat congestion in patients with heart failure and edema in patients with chronic kidney disease. Furoscix is a novel formulation of furosemide contained in a pre-filled, Crystal Zenith cartridge and self-administered subcutaneously via a single-use, disposable, and wearable on-body delivery system.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Core
- Total Number of Employees
- 96
Valuation
|
Metric
|
SCPH
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 5.89 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
SCPH
|
|---|---|
Quick Ratio | 2.95 |
Current Ratio | 3.85 |
Interest Coverage | −14.49 |
Quick Ratio
SCPH
Profitability
|
Metric
|
SCPH
|
|---|---|
Return on Assets (Normalized) | −80.13% |
Return on Equity (Normalized) | −1,401.10% |
Return on Invested Capital (Normalized) | −129.78% |
Return on Assets
SCPH
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|M%m!B^K | LOCK|?c!? | $133B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|kv??Q!f | LOCK|&%y@ | $83B | |||
| Moderna Inc
MRNA
| LOCK|DWk#%p& | LOCK|@fF | $80B | |||
| argenx SE ADR
ARGX
| LOCK|Zt<<!J | LOCK|vz | $55B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|kcF!$r | LOCK|wY | $45B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|!&h?Gd | LOCK|#%%< | $30B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|sjNcv>!@ | LOCK|pxq# | $28B | |||
| Incyte Corp
INCY
| LOCK|&hb<cB | LOCK|?h | $23B | |||
| BioNTech SE ADR
BNTX
| LOCK|B$v&!! | LOCK|pc | $22B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|h&#Z&tT | LOCK|SLk | $14B |
United States